IPH5201 is a human IgG1 monoclonal antibody (mAb) targeting ENTPD1/CD39. It enhances the accumulation of immunostimulatory ATP released by tumor cells undergoing combination chemotherapy (CT) and reduces the levels of immunosuppressive adenosine (Ado) in the tumor microenvironment (TME). IPH5201 is useful for research on antitumor immunity. Recommended isotype control: Human IgG1 kappa, Isotype Control.
Target:
Phosphatase
* VAT and and shipping costs not included. Errors and price changes excepted
